Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001738 · ClinicalTrials.gov registry record
Vascular Endothelial Growth Factor (VEGF) in Uveitis
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 60
- Enrollment target
NCT00001738 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 60 participants.
The verdict
NCT00001738 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study will look for the presence in blood of a substance called vascular endothelial growth factor (VEGF) in patients with uveitis (eye inflammation). It will also look for this substance in eye fluid samples taken from patients with uveitis who are undergoing eye surgery. Some patients with uveitis experience some vision loss during an inflammatory attack because of swelling (edema) in a particular area of the retina called the macula, which is involved in visual acuity. It may be that VEGF is involved in the development of macular edema. Patients with uveitis who participate in this study will have about 10 cc (2 teaspoons) of blood drawn to be examined for VEGF. They will also undergo a procedure called fluorescein angiography to look at the blood vessels of the eye. A dye called sodium fluorescein is injected into the blood stream through a vein. After the dye reaches the blood vessels of the eye, photographs are taken of the retina. In addition, patients with uveitis who are undergoing eye surgery will have a tissue specimen (either aqueous fluid or vitreous gel) collected for examination for the presence of VEGF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1998-08 |
| Est. Completion | 2000-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001738
The ClinicalTrials.gov registry entry for NCT00001738 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001738 about?
NCT00001738 is a clinical study titled "Vascular Endothelial Growth Factor (VEGF) in Uveitis". This study will look for the presence in blood of a substance called vascular endothelial growth factor (VEGF) in patients with uveitis (eye inflammation). It will also look for this substance in eye fluid samples taken from patients with uveitis who are undergoing eye surgery. Some patients with u...
What is the current status of trial NCT00001738?
This trial is currently completed. The enrollment target is 60 participants. The study started on 1998-08. Estimated completion is 2000-06.
Who is sponsoring clinical trial NCT00001738?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.